Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

ICON Builds China Presence by Acquiring BeijingWits, a Clinical CRO

publication date: Dec 12, 2011
ICON plc, a global CRO based in Ireland, made good on a promise to increase its China presence by acquiring a China clinical-stage CRO, BeijingWits Medical Consulting. Founded in 1997, BeijingWits offers Phase I-IV clinical trial services and claims expertise in China’s regulatory processes. ICON said the transaction would add 100 experienced personnel to its China staff. Terms were not disclosed. More details....

Stock Symbol: (NSDQ: ICLR)     Share this with colleagues:  

 


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital